» Articles » PMID: 37597798

Age-Accelerated Increase of White Matter Hyperintensity Volumes Is Exacerbated by Heavy Alcohol Use in People Living With HIV

Overview
Journal Biol Psychiatry
Publisher Elsevier
Specialty Psychiatry
Date 2023 Aug 19
PMID 37597798
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Antiretroviral treatment has enabled people living with HIV infection to have a near-normal life span. With longevity comes opportunities for engaging in risky behavior, including initiation of excessive drinking. Given that both HIV infection and alcohol use disorder (AUD) can disrupt brain white matter integrity, we questioned whether HIV infection, even if successfully treated, or AUD alone results in signs of accelerated white matter aging and whether HIV+AUD comorbidity further accelerates brain aging.

Methods: Longitudinal magnetic resonance imaging-FLAIR data were acquired over a 15-year period from 179 control individuals, 204 participants with AUD, 70 participants with HIV, and 75 participants with comorbid HIV+AUD. White matter hyperintensity (WMH) volumes were quantified and localized, and their functional relevance was examined with cognitive and motor testing.

Results: The 3 diagnostic groups each had larger WMH volumes than the control group. Although all 4 groups exhibited accelerating volume increases with aging, only the HIV groups showed faster WMH enlargement than control individuals; the comorbid group showed faster acceleration than the HIV-only group. Sex and HIV infection length, but not viral suppression status, moderated acceleration. Correlations emerged between WMH volumes and attention/working memory and executive function scores of the AUD and HIV groups and between WMH volumes and motor skills in the 3 diagnostic groups.

Conclusions: Even treated HIV can show accelerated aging, possibly from treatment sequelae or legacy effects, and notably from AUD comorbidity. WMH volumes may be especially relevant for tracking HIV and AUD brain health because each condition is associated with liability for hypertensive processes, for which WMHs are considered a marker.

Citing Articles

The Interaction Between Cognitive Abilities and White Matter Hyperintensity Phenotypes: A Novel Perspective on Bidirectional Causality.

Ren X, Li T, Li F, Liu S Brain Behav. 2025; 15(2):e70313.

PMID: 39925008 PMC: 11808190. DOI: 10.1002/brb3.70313.


Serum albumin and white matter hyperintensities.

Zahr N, Pfefferbaum A Transl Psychiatry. 2024; 14(1):233.

PMID: 38824150 PMC: 11144249. DOI: 10.1038/s41398-024-02953-5.


Alcohol Use Disorder and Dementia: A Review.

Zahr N Alcohol Res. 2024; 44(1):03.

PMID: 38812709 PMC: 11135165. DOI: 10.35946/arcr.v44.1.03.


Contributions of Cerebral White Matter Hyperintensities to Postural Instability in Aging With and Without Alcohol Use Disorder.

Sullivan E, Zahr N, Zhao Q, Pohl K, Sassoon S, Pfefferbaum A Biol Psychiatry Cogn Neurosci Neuroimaging. 2024; 9(10):998-1009.

PMID: 38569932 PMC: 11442683. DOI: 10.1016/j.bpsc.2024.03.005.


Contributions of cerebral white matter hyperintensities, age, and pedal perception to postural sway in people with HIV.

Sullivan E, Zahr N, Zhao Q, Pohl K, Sassoon S, Pfefferbaum A AIDS. 2024; 38(8):1153-1162.

PMID: 38537080 PMC: 11141235. DOI: 10.1097/QAD.0000000000003894.


References
1.
Sanford R, Strain J, Dadar M, Maranzano J, Bonnet A, Mayo N . HIV infection and cerebral small vessel disease are independently associated with brain atrophy and cognitive impairment. AIDS. 2019; 33(7):1197-1205. PMC: 7924885. DOI: 10.1097/QAD.0000000000002193. View

2.
Mina Y, Wu T, Hsieh H, Hammoud D, Shah S, Lau C . Association of White Matter Hyperintensities With HIV Status and Vascular Risk Factors. Neurology. 2021; 96(14):e1823-e1834. PMC: 8105972. DOI: 10.1212/WNL.0000000000011702. View

3.
Murray K, Uddin M, Tivarus M, Sahin B, Wang H, Singh M . Increased risk for cerebral small vessel disease is associated with quantitative susceptibility mapping in HIV infected and uninfected individuals. Neuroimage Clin. 2021; 32:102786. PMC: 8429957. DOI: 10.1016/j.nicl.2021.102786. View

4.
Soontornniyomkij V, Umlauf A, Chung S, Cochran M, Soontornniyomkij B, Gouaux B . HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS. 2014; 28(9):1297-306. PMC: 4071161. DOI: 10.1097/QAD.0000000000000262. View

5.
van Dinther M, Voorter P, Jansen J, Jones E, van Oostenbrugge R, Staals J . Assessment of microvascular rarefaction in human brain disorders using physiological magnetic resonance imaging. J Cereb Blood Flow Metab. 2022; 42(5):718-737. PMC: 9014687. DOI: 10.1177/0271678X221076557. View